PRICE T ROWE ASSOCIATES INC /MD/
Position in ACRS — Aclaris Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in ACRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,172,258
+$584,540 QoQ
Shares Held
221,599
+41.4% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 149 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. ACRS ranks #171 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in ACRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,172,258 | 221,599 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $587,718 | 156,725 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $421,902 | 140,167 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $266,317 | 140,167 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $236,241 | 166,367 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $188,343 | 123,100 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $305,288 | 123,100 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $160,310 | 139,400 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $153,340 | 139,400 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $136,111 | 109,767 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $113,940 | 108,515 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $889,725 | 129,887 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $507,922 | 48,980 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $384,016 | 47,468 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $735,714 | 46,712 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $741,448 | 47,106 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $530,884 | 38,029 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $544,249 | 31,569 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $470,267 | 32,343 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $589,356 | 32,742 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $737,116 | 41,977 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $733,824 | 29,120 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||